Pharmaceutical

Disc wins orphan drug tag for rare blood cancer  

The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I clinical trial, with data expected this year.

Feb 12, 2024 - 18:00
Disc wins orphan drug tag for rare blood cancer  
The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I clinical trial, with data expected this year.
Read the original article

Tags:

Previous Article

Science and menopause under the spotlight during the Super Bowl

Next Article

First targeted alpha therapy wins FDA breakthrough device designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility

STAT+: Pharmalittle: Illumina will divest Grail after c...

Dec 19, 2023

STAT+: Novocure’s electric fields device prolongs survival in lung cancer, but doubts remain

STAT+: Novocure’s electric fields device prolongs survi...

Jun 6, 2023

STAT+: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan

STAT+: Ron DeSantis wants to import drugs from Canada. ...

Aug 23, 2023